Free Annual Reports
Gilead Among Healthcare's Biggest Movers on November 12, 2012
The Nasdaq has decreased 0.1%, the S&P 500 has moved little and the Dow is trading down 0.1% so far today. The healthcare sector is the category of stocks relating to medical and healthcare goods or services. This sector includes hospital management firms, health maintenance organizations (HMOs), biotechnology and a variety of medical products. Stocks in the healthcare sector are often considered to be defensive because the products and services are essential. Even during economic downturns, people will still require medical aid and medicine to overcome illness. Having a consistent demand for goods and services makes this sector less sensitive to business cycle fluctuations.
Beginner's Guide To Thinkorswim Trading Platform
After a big jump of 12.4%, Sarepta Therapeutics (Nasdaq:SRPT) is trading at $25.58 per share. So far today, 1.9 million shares have changed hands.
Gilead (Nasdaq:GILD) has soared 12.3% to reach a current price of $73 per share. So far today, 13.7 million shares have changed hands, which is more trading activity than there was yesterday.
Achillion Pharmaceuticals (Nasdaq:ACHN) is at a share price of $7.91 after a sharp decline of 12.3%. So far today, 3.4 million shares have changed hands. This is 3.7 times its average volume over the past three months.
Nektar (Nasdaq:NKTR) is trading at $7.34 per share, down 9.9%. The company's volume is currently five million shares for the day, 4.9 times the current daily average.
Celgene (Nasdaq:CELG) is at $75.42 per share after an increase of 5.5%. This morning, the company is trading a volume of five million shares.
Increasing 4%, Cyberonics (Nasdaq:CYBX) is trading at $46.28 per share. The company's volume is currently 66,098 shares for the day, lighter than yesterday's volume of 196,176 shares.
Endo Pharmaceuticals Holdings (Nasdaq:ENDP) is currently trading at $26.97 per share, a 3.2% increase. This morning, the company is trading a volume of 1.4 million shares. This is consistent with its current three-month average.
The Bottom Line No matter the economic climate, Wall Street will always have stocks that make major moves each week. Daily stock performance should be weighed against historical performance and put in context of the market overall. However, these fundamental metrics must be analyzed with historic data, industry information in addition to firm specific financial statements.
| Company | Market Cap | Percentage Change |
| Sarepta Therapeutics (Nasdaq:SRPT) | $579.1 million | +12.4% |
| Gilead (Nasdaq:GILD) | $49.25 billion | +12.3% |
| Achillion Pharmaceuticals (Nasdaq:ACHN) | $716.5 million | -12.3% |
| Nektar (Nasdaq:NKTR) | $936.5 million | -9.9% |
| Celgene (Nasdaq:CELG) | $30.24 billion | +5.5% |
| Cyberonics (Nasdaq:CYBX) | $1.23 billion | +4% |
| Endo Pharmaceuticals Holdings (Nasdaq:ENDP) | $2.98 billion | +3.2% |
After a big jump of 12.4%, Sarepta Therapeutics (Nasdaq:SRPT) is trading at $25.58 per share. So far today, 1.9 million shares have changed hands.
Gilead (Nasdaq:GILD) has soared 12.3% to reach a current price of $73 per share. So far today, 13.7 million shares have changed hands, which is more trading activity than there was yesterday.
Achillion Pharmaceuticals (Nasdaq:ACHN) is at a share price of $7.91 after a sharp decline of 12.3%. So far today, 3.4 million shares have changed hands. This is 3.7 times its average volume over the past three months.
Celgene (Nasdaq:CELG) is at $75.42 per share after an increase of 5.5%. This morning, the company is trading a volume of five million shares.
Increasing 4%, Cyberonics (Nasdaq:CYBX) is trading at $46.28 per share. The company's volume is currently 66,098 shares for the day, lighter than yesterday's volume of 196,176 shares.
Endo Pharmaceuticals Holdings (Nasdaq:ENDP) is currently trading at $26.97 per share, a 3.2% increase. This morning, the company is trading a volume of 1.4 million shares. This is consistent with its current three-month average.
The Bottom Line No matter the economic climate, Wall Street will always have stocks that make major moves each week. Daily stock performance should be weighed against historical performance and put in context of the market overall. However, these fundamental metrics must be analyzed with historic data, industry information in addition to firm specific financial statements.
by
Investopedia Staff
Investopedia.com believes that individuals can excel at managing their financial affairs. As such, we strive to provide free educational content and tools to empower individual investors, including thousands of original and objective articles and tutorials on a wide variety of financial topics.
Free Annual Reports
